Journal of Pharmacy and Pharmaceutical Sciences

Papers
(The median citation count of Journal of Pharmacy and Pharmaceutical Sciences is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Therapeutic update on oral potassium exchange resin use in chronic kidney disease patients: a systematic review of randomized controlled clinical trials102
The need to redefine diabetic cardiomyopathy as a unique clinical entity that requires pharmacotherapy80
Monkeypox: Virology, Pathophysiology, Clinical Characteristics, Epidemiology, Vaccines, Diagnosis, and Treatments41
Evaluating the Effects of Agomelatine on Polysomnography Parameters in Patients with Obstructive Sleep Apnea.36
Drug-disease interaction: Clinical consequences of inflammation on drugs action and disposition34
Comparing broad and narrow phenotype algorithms: differences in performance characteristics and immortal time incurred32
Corrigendum: Applications of exhaled breath condensate analysis for drug monitoring and bioequivalence study of inhaled drugs30
Effect of Oregon grape root extracts on P-glycoprotein mediated transport in in vitro cell lines26
Effect of Concomitant Drug Use on the Onset and Exacerbation of Diabetes Mellitus in Everolimus-Treated Cancer23
Applications of Exhaled Breath Condensate Analysis for Drug Monitoring and Bioequivalence Study of Inhaled Drugs21
Pharmacological increases in circulating ketones fail to alleviate the hypertrophic cardiomyopathy present in the Tafazzin knockdown mouse model of Barth syndrome18
Network pharmacology and molecular docking reveal the immunomodulatory mechanism of rhubarb peony decoction for the treatment of ulcerative colitis and irritable bowel syndrome18
Forkhead box O1 transcription factor; a therapeutic target for diabetic cardiomyopathy17
Post-Marketing Safety of Vemurafenib: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System16
Expanding the eligibility criteria for drugs in Canada’s time-limited health technology assessment and temporary drug access processes will further accelerate access to new medicines16
From fasting to fat reshaping: exploring the molecular pathways of intermittent fasting-induced adipose tissue remodeling16
Real-world community hospital hyperglycemia management in noncritically ill, type 2 diabetic patients: a comparison between basal-bolus insulin and correctional insulin15
Effects of dual therapy with betamethasone and tetracycline in a NC/Nga mouse model of atopic dermatitis15
Refined pharmacovigilance assessment of immune checkpoint inhibitors-related bullous pemphigoid: a multi-methodological approach utilizing FAERS database14
Exploring the Role of Sodium-Glucose Cotransporter as a New Target for Cancer Therapy14
Community pharmacists as antimicrobial resistance stewards: a narrative review on their contributions and challenges in low- and middle-income countries13
Gastrointestinal perforation associated with novel antineoplastic agents: A real-world study based on the FDA Adverse Event Reporting System12
Intrahepatic cholestasis of pregnancy associated with azathioprine: first quantitative disproportionality analysis using the FDA adverse event reporting system12
Remdesivir-induced conduction abnormalities: A molecular model-based explanation12
Data collection within patient support programs in Canada and implications for real-world evidence generation: the authors’ perspective10
Metabolic flux in macrophages in obesity and type-2 diabetes10
The Effect of HIV/AIDS Infection on the Clinical Outcomes of COVID-19: A Meta-Analysis10
Development of a submicron emulsion-based delivery system to improve the anti-inflammatory activity of urolithin A10
Integration of real-world evidence from different data sources in health technology assessment9
Evaluation of hematocrit-adjusted conversion strategies for mycophenolic acid and tacrolimus monitoring using volumetric absorptive microsampling in lung and renal transplant recipients8
The role of acetylation in obesity-induced cardiac metabolic alterations8
Development of a dry powder formulation for pulmonary delivery of azithromycin-loaded nanoparticles8
Formulating biopharmaceuticals using three-dimensional printing8
Clinical observation of dexmedetomidine nasal spray in the treatment of sleep disorders on the first night after undergoing maxillofacial surgery: a single-center double-blind randomized controlled st7
Persistence and switching patterns of migraine prophylactic medications in Canada: A retrospective claims analysis comparing adherence and evaluating the economic burden of illness7
A review to determine regulatorily and reimbursement successes of studies conducted using data from Canadian patient support programs based on the real-world evidence guidelines published by Canadian 7
Occurrence of intraocular hemorrhages under monotherapy or combination therapy of antiplatelets and anticoagulants using the Japanese Adverse Drug Event Report database6
Analysis of Prednisolone-Induced Osteoporosis Using the Japanese Adverse Drug Event Report Database6
Qualitative phytochemical profiling, antioxidant activity, and development of a water-in-oil cream containing combined oil and water infusions of frankincense resin (Boswellia spp.): a preliminary in 6
A Survey of the Criteria Used for the Selection of Alternative Comparator Products by Participating Regulators and Organizations of the International Pharmaceutical Regulators Programme6
Adverse drug events associated with tiotropium: a real-world pharmacovigilance study of FDA adverse event reporting system database6
Chitosan non-particulate vaccine delivery systems6
Compounding and stability studies of liquid oral formulations of beta-blockers (bisoprolol, betaxolol, and nadolol) for paediatric patients6
Weighing in on the role of brown adipose tissue for treatment of obesity5
A Review of Electronic Cigarettes and Liquid Nicotine Poisoning Exposure Cases in the United States5
The mechanism of Leonuri Herba in improving polycystic ovary syndrome was analyzed based on network pharmacology and molecular docking5
Zaleplon nanospanlastics loaded transdermal patches: formulation, optimization, ex-vivo permeation, and in-vivo studies5
Rethinking asthma therapy, part 1: transdermal delivery of β2-agonists4
Corrigendum: Recent progress of polymeric microneedle-assisted long-acting transdermal drug delivery4
Development of modular polymeric nanoparticles for drug delivery using amine reactive chemistry4
Targeted therapy and biomarker-guided applications of ecofriendly silver nanoparticles in precision oncology4
Erratum to 'Piecing Together Human Adult Comparative Pharmacokinetic Trials and Rodent Studies: What Happens to Drug Clearance in Obesity?'4
Targeting ketone body metabolism to treat fatty liver disease3
Film dressings from Thai mango seed kernel extracts versus nanocrystalline silver dressings in antibacterial properties3
COVID-19 mRNA vaccination is associated with IgA nephropathy: an analysis of the Japanese adverse drug event report database3
Harnessing DNA polymerase beta defect enhances synthetic lethality and treatment response in gastric cancer cells: implication for immunotherapy3
Personalizing immunosuppressive therapy: predictors of drug switches in Malaysian kidney transplant recipients3
Safety and efficacy of phosphodiesterase-5 (PDE-5) inhibitors in fetal growth restriction: a systematic literature review and meta-analysis3
Grading pharmacists’ risk of complaints to a regulator: A retrospective cohort study3
0.036817789077759